---
layout: post
title: USAN Watch - January 2012
date: '2012-01-14T04:30:00.003Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2012-02-14T16:17:59.055Z'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-2193047465383713769
blogger_orig_url: http://chembl.blogspot.com/2012/01/usan-watch-january-2012.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
The USANs for January 2012 have just been published.<br />
<br />
<table border="1"><tbody>
<tr><td><b>USAN </b></td><td><b>Research Code </b></td><td><b>Structure</b></td><td><b>Drug Class</b></td><td><b>Therapeutic class</b></td><td><b>Target</b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/arhalofenate.pdf">arhalofenate</a></td><td>MBX-102, JNJ-39,659,100</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-Ep6k8dNtlz0/TxEC_zj2JxI/AAAAAAAABeU/uw3q7ynLqnY/s1600/arhalofenate.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-Ep6k8dNtlz0/TxEC_zj2JxI/AAAAAAAABeU/uw3q7ynLqnY/s1600/arhalofenate.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>PPAR-gamma</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/bitopertin.pdf">bitopertin</a></td><td>Ro-4917838</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://1.bp.blogspot.com/-vRzhxG2edwE/TxEDItK49dI/AAAAAAAABec/i3nur0e40IU/s1600/bitopterin.png" imageanchor="1"><img border="0" src="http://1.bp.blogspot.com/-vRzhxG2edwE/TxEDItK49dI/AAAAAAAABec/i3nur0e40IU/s1600/bitopterin.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>GlyT1</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/naldemedine.pdf">naldemedine</a></td><td>S-297,995</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://2.bp.blogspot.com/-wKw3een0OX8/TxEDQEdrdbI/AAAAAAAABek/-X6G4G8K594/s1600/naldemedine.png" imageanchor="1"><img border="0" src="http://2.bp.blogspot.com/-wKw3een0OX8/TxEDQEdrdbI/AAAAAAAABek/-X6G4G8K594/s1600/naldemedine.png" style="cursor: move;" /></a></span></td><td>natural product-derived small molecule</td><td>therapeutic</td><td>peripheral opioid receptors</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pateclizumab.pdf">pateclizumab</a></td><td>RG-7416, PRO-283698, MLTA-3698A</td><td></td><td>mab</td><td>therapeutic</td><td>lymphotoxin alpha</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/pictilisib.pdf">pictilisib</a></td><td>GDC-0941, RG-7321</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://4.bp.blogspot.com/-fI60eCCfrno/TxEDYYl4U0I/AAAAAAAABes/LUSbDFZlIYo/s1600/pictilisib.png" imageanchor="1"><img border="0" src="http://4.bp.blogspot.com/-fI60eCCfrno/TxEDYYl4U0I/AAAAAAAABes/LUSbDFZlIYo/s1600/pictilisib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>PI3K, mTor</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/tivozanib.pdf">tivozanib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/tivozanib-hydrochloride.pdf">tivozanib hydrochloride</a></td><td>AV-951, Kil-8951</td><td><span class="Apple-style-span" style="-webkit-border-horizontal-spacing: 0px; -webkit-border-vertical-spacing: 0px;"><a href="http://3.bp.blogspot.com/-dI8KXjXPbbo/TxEDeqGFa5I/AAAAAAAABe0/tVKo1s9MgN0/s1600/Tivozanib.png" imageanchor="1"><img border="0" src="http://3.bp.blogspot.com/-dI8KXjXPbbo/TxEDeqGFa5I/AAAAAAAABe0/tVKo1s9MgN0/s1600/Tivozanib.png" style="cursor: move;" /></a></span></td><td>synthetic small molecule</td><td>therapeutic</td><td>VEGFR</td></tr>
</tbody></table>
Update: Fixed research code for Pactelizumab - thanks to Robert Jones (details in the comments).